Rare diseases
Investigational molecules
Locations
Study on Anifrolumab for Adults with Chronic or Subacute Cutaneous Lupus Erythematosus Unresponsive to Antimalarial Therapy
ItalyStudy of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease
ItalyStudy of petosemtamab compared to standard therapy in previously treated patients with metastatic or recurrent head and neck cancer
ItalyStudy of Sotatercept for Patients with Severe Pulmonary Arterial Hypertension at High Risk of Mortality
ItalyStudy of Cabozantinib and Atezolizumab Compared to Hormonal Therapy in Adults with Metastatic Castration-Resistant Prostate Cancer
ItalyStudy of OPT-302 and Aflibercept for Patients with Wet Age-related Macular Degeneration
ItalyStudy of Exagamglogene Autotemcel (CTX001) for Treatment of Severe Sickle Cell Disease Using Modified Stem Cells
ItalyStudy on BI 1819479 to Improve Lung Function in Patients with Idiopathic Pulmonary Fibrosis
ItalyStudy of Pembrolizumab with Cisplatin or Carboplatin and Pemetrexed for Patients with Resectable Malignant Pleural Mesothelioma
ItalyStudy on the Safety of Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy Who Completed a Previous Trial
ItalyStudy of Domvanalimab, Zimberelimab, and Chemotherapy for Patients with Advanced Esophageal or Gastric Cancer
ItalyStudy on Rituximab, Bendamustine, Cytarabine, and Venetoclax for High-Risk Elderly Patients with Mantle Cell Lymphoma
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
